Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

NASDAQ:CREX - Nasdaq - US22530J3095 - Common Stock - Currency: USD

2.42  -0.13 (-5.1%)

Fundamental Rating

3

Overall CREX gets a fundamental rating of 3 out of 10. We evaluated CREX against 93 industry peers in the Media industry. CREX has a bad profitability rating. Also its financial health evaluation is rather negative. CREX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CREX had positive earnings in the past year.
In the past year CREX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

CREX has a Return On Assets of 1.11%. This is comparable to the rest of the industry: CREX outperforms 59.77% of its industry peers.
CREX has a Return On Equity of 2.65%. This is comparable to the rest of the industry: CREX outperforms 58.62% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.64%, CREX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 1.11%
ROE 2.65%
ROIC 5.64%
ROA(3y)-0.1%
ROA(5y)-15.78%
ROE(3y)-0.07%
ROE(5y)-76.52%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

CREX's Profit Margin of 1.38% is in line compared to the rest of the industry. CREX outperforms 57.47% of its industry peers.
Looking at the Operating Margin, with a value of 6.68%, CREX is in line with its industry, outperforming 49.43% of the companies in the same industry.
With a Gross Margin value of 49.05%, CREX perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
CREX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.68%
PM (TTM) 1.38%
GM 49.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y1.56%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

CREX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CREX has more shares outstanding
Compared to 5 years ago, CREX has more shares outstanding
Compared to 1 year ago, CREX has an improved debt to assets ratio.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of 0.04. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CREX (0.04) is worse than 77.01% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that CREX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.77, CREX perfoms like the industry average, outperforming 50.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.04
ROIC/WACC0.6
WACC9.45%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

A Current Ratio of 0.58 indicates that CREX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.58, CREX is doing worse than 90.80% of the companies in the same industry.
A Quick Ratio of 0.47 indicates that CREX may have some problems paying its short term obligations.
CREX has a worse Quick ratio (0.47) than 91.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.47
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

CREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.28%, which is quite impressive.
Looking at the last year, CREX shows a very strong growth in Revenue. The Revenue has grown by 31.80%.
CREX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.97% yearly.
EPS 1Y (TTM)109.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.55%
Revenue 1Y (TTM)31.8%
Revenue growth 3Y37.27%
Revenue growth 5Y14.97%
Sales Q2Q%24.84%

3.2 Future

Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 45.62% on average per year.
The Revenue is expected to grow by 14.88% on average over the next years. This is quite good.
EPS Next Y49.15%
EPS Next 2Y52.81%
EPS Next 3Y45.62%
EPS Next 5YN/A
Revenue Next Year7.48%
Revenue Next 2Y12.41%
Revenue Next 3Y14.88%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CREX is valuated rather expensively with a Price/Earnings ratio of 17.29.
63.22% of the companies in the same industry are more expensive than CREX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CREX is valued a bit cheaper.
A Price/Forward Earnings ratio of 20.63 indicates a rather expensive valuation of CREX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 63.22% of the companies listed in the same industry.
CREX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 17.29
Fwd PE 20.63
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CREX is valued cheaper than 87.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.81
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 45.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y52.81%
EPS Next 3Y45.62%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CREX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CREATIVE REALITIES INC

NASDAQ:CREX (2/21/2025, 8:10:52 PM)

2.42

-0.13 (-5.1%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)03-19 2025-03-19/bmo
Inst Owners19.74%
Inst Owner Change11.66%
Ins Owners16.24%
Ins Owner Change0%
Market Cap25.29M
Analysts84
Price Target7.65 (216.12%)
Short Float %0.14%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.19%
Min EPS beat(2)21.57%
Max EPS beat(2)158.81%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)1.87%
Max Revenue beat(2)2.07%
Revenue beat(4)2
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-11.41%
Max Revenue beat(4)2.07%
Revenue beat(8)2
Avg Revenue beat(8)-5.21%
Revenue beat(12)2
Avg Revenue beat(12)-3.98%
Revenue beat(16)2
Avg Revenue beat(16)-5.45%
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)-354.44%
EPS NQ rev (3m)-205%
EPS NY rev (1m)-302.72%
EPS NY rev (3m)-302.72%
Revenue NQ rev (1m)-30.53%
Revenue NQ rev (3m)-38.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.08%
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 20.63
P/S 0.47
P/FCF N/A
P/OCF 15.7
P/B 0.89
P/tB N/A
EV/EBITDA 4.81
EPS(TTM)0.14
EY5.79%
EPS(NY)0.12
Fwd EY4.85%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)0.15
OCFY6.37%
SpS5.2
BVpS2.71
TBVpS-2.07
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 2.65%
ROCE 9.06%
ROIC 5.64%
ROICexc 5.74%
ROICexgc N/A
OM 6.68%
PM (TTM) 1.38%
GM 49.05%
FCFM N/A
ROA(3y)-0.1%
ROA(5y)-15.78%
ROE(3y)-0.07%
ROE(5y)-76.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y1.56%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 2.96
Cap/Depr 85.57%
Cap/Sales 5.88%
Interest Coverage 2.76
Cash Conversion 21.9%
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.47
Altman-Z 0.04
F-Score6
WACC9.45%
ROIC/WACC0.6
Cap/Depr(3y)120.64%
Cap/Depr(5y)96.12%
Cap/Sales(3y)8.37%
Cap/Sales(5y)6.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.55%
EPS Next Y49.15%
EPS Next 2Y52.81%
EPS Next 3Y45.62%
EPS Next 5YN/A
Revenue 1Y (TTM)31.8%
Revenue growth 3Y37.27%
Revenue growth 5Y14.97%
Sales Q2Q%24.84%
Revenue Next Year7.48%
Revenue Next 2Y12.41%
Revenue Next 3Y14.88%
Revenue Next 5YN/A
EBIT growth 1Y302.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5874.41%
EBIT Next 3Y396.97%
EBIT Next 5YN/A
FCF growth 1Y60.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y867.14%
OCF growth 3YN/A
OCF growth 5YN/A